| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |